Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Prepaid Assets (2016 - 2025)

Cartesian Therapeutics (RNAC) has disclosed Prepaid Assets for 11 consecutive years, with $3.0 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets fell 3.88% to $3.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.0 million through Dec 2025, down 3.88% year-over-year, with the annual reading at $3.0 million for FY2025, 3.88% down from the prior year.
  • Prepaid Assets for Q4 2025 was $3.0 million at Cartesian Therapeutics, down from $3.2 million in the prior quarter.
  • The five-year high for Prepaid Assets was $8.2 million in Q2 2021, with the low at $2.0 million in Q2 2024.
  • Average Prepaid Assets over 5 years is $4.5 million, with a median of $4.0 million recorded in 2023.
  • The sharpest move saw Prepaid Assets surged 686.4% in 2021, then tumbled 52.0% in 2024.
  • Over 5 years, Prepaid Assets stood at $6.5 million in 2021, then crashed by 41.64% to $3.8 million in 2022, then soared by 31.47% to $5.0 million in 2023, then tumbled by 36.7% to $3.1 million in 2024, then dropped by 3.88% to $3.0 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $3.0 million, $3.2 million, and $2.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.